TrialEuropean journal of cancer (Oxford, England : 1990)2020

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.

Axel Hauschild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.